BMEZ News and Press, BlackRock Health Sciences Trust II of Beneficial Interest From 09/29/21

Market volatility has been ramping up throughout the month of September as historically it has been the weakest month. We are at historically narrow discounts/premiums for closed-end funds and that could mean things get even more volatile. Typically, staying the course and continu...

BMEZ's latest report shows significant realized gains, mostly enough to cover the distribution for the year, all else being equal. BMEZ is a fund focused on healthcare but allows exposure to small to mid-sized and private healthcare companies. The focus on these types of assets ca...

BIGZ was launched earlier this year and has since done a lot of nothing in terms of movement. The fund launched at a $20 NAV and last closed at $19.96, a large move with the prior close helped add $0.55 (August 27th). I view BIGZ as a long-term type holding that can provide income...

Last year, we were looking at distribution changes due to the COVID pandemic sell-off. CEFs distribute out most of their earnings as distributions, so they pay relatively higher yields. However, relatively higher yields mean that any downturn is likely to cause distribution cuts. ...

NBXG was launched several months ago and now we are starting to get some initial information. The fund seems interesting at this time and could provide for some good exposure; however, perhaps waiting until it gets more of a track record could be the best approach. After trading a...

While the size of the listed CEF universe pales in comparison to open-end mutual funds or ETFs, CEFs offer investors several potential benefits that are often overlooked. CEFs can offer access to high-growth private markets in an investor-friendly structure. Unlike mutual funds an...

THQ has been moving higher throughout 2021, after an already great year for the fund in 2020. The sell-off last year was brief but it was even more brief for THQ shareholders as the fund snapped back aggressively. If the Delta variant of the COVID virus sends countries back into l...

BMEZ is a fund focused on the growth side of healthcare, with exposure to some private investments. Private investments can be quite lucrative as it is participating before public launches that can see shares rise spectacularly. On the other side of this large potential is a highe...

Closed-ends funds as a whole have become quite stretched in value, this isn't any different for HQH. HQH holds an overweight exposure to biotech in the healthcare space - as the biotech space has been cooling down so has HQH. If you are a current shareholder, I believe it still ma...

When I get a question on a CEF or am looking at a new CEF, these are the first 5 things I will check. The five places I want to look first are; 1. Investment Policy, 2. Quick Review of Holdings, 3. Discount/Premium, 4. Performance, 5. Distributions. Once these items are checked, I...